Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.
about
Inhibition of B virus (Macacine herpesvirus 1) by conventional and experimental antiviral compounds.Fluorinated Nucleosides: Synthesis and Biological ImplicationEffects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: 18F-FAU, 18F-FMAU, and 18F-FLT.Current status of anti-HBV chemotherapy.Synthesis of 2′-Deoxy-2′ -Fluoro-D-Arabinopyranopyranosyl Nucleosides and Their 3′,4′-Seco analogues
P2860
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Phase I trial of 1-
@nl
Phase I trial of 1-(2'-deoxy-2 ...... by severe neurologic toxicity.
@en
type
label
Phase I trial of 1-
@nl
Phase I trial of 1-(2'-deoxy-2 ...... by severe neurologic toxicity.
@en
prefLabel
Phase I trial of 1-
@nl
Phase I trial of 1-(2'-deoxy-2 ...... by severe neurologic toxicity.
@en
P2093
P356
P1476
Phase I trial of 1-(2'-deoxy-2 ...... by severe neurologic toxicity.
@en
P2093
A M Castellanos
I H Krakoff
J L Abbruzzese
P2888
P304
P356
10.1007/BF00170857
P577
1989-07-01T00:00:00Z